Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
11/2000
11/02/2000CA2370238A1 A process for purification of proanthocyanidin oligomer
11/01/2000CN1272107A Benzamidine derivatives as factor Xa inhibitors
10/2000
10/31/2000US6140505 Synthesis of benzo fused heterocyclic sulfonyl chlorides
10/31/2000US6140385 Photoactive compounds for use with narrow wavelength band ultraviolet (UV) curing systems
10/31/2000US6140358 Substituted phenyl keto enols as pesticides and herbicides
10/31/2000US6139872 Method of producing a vitamin product
10/26/2000WO2000063201A1 Synthetic methods for preparing procyanidin oligomers
10/26/2000WO2000063166A1 Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands
10/26/2000WO2000062765A2 ESTROGEN RECEPTOR-β LIGANDS
10/26/2000WO2000039120A3 Compounds and methods for modulation of estrogen receptors
10/26/2000CA2370126A1 Estrogen receptor-.beta. ligands
10/26/2000CA2369799A1 Synthetic methods for preparing procyanidin oligomers
10/25/2000EP1046396A2 Soy protein and plant sterol containing composition for the reduction of low density lipoprotein cholesterol concentration
10/25/2000EP1045841A1 Novel genipin derivative having liver protection activity
10/25/2000CN1271357A bisethers of 1-oxa, aza and thianaphthalen-2-ones as phospholamban inhibitors
10/24/2000US6137002 Glycoprotein IIb/IIIa antagonists
10/24/2000US6136986 Reacting substituted acrolein compound with acrylates, acroleins, acrolein acetals, allyl alcohols or allyl ethers to give 3,4-dihydro-2h-pyrans, reacting with acid, followed by reacting with substitueted vinyl ketone, dehydrogenation
10/24/2000US6136985 CLA esters and uses thereof
10/24/2000US6136851 Skin disorders
10/24/2000US6136849 Antibacterial and antifungal flavanones from Eysenhardtia texana
10/24/2000US6136848 Antiallergens; asthma therapy
10/24/2000US6136839 Using a sulfone or sulfoamide benzene compound
10/24/2000US6136800 Steroids
10/19/2000WO2000061547A1 8-8, 6-6 and 6-8 catechin and epicatechin dimers and methods for their preparation
10/19/2000WO2000061542A1 Caspase inhibitors and the use thereof
10/19/2000WO2000061142A1 Method and composition for the treatment of cancer
10/19/2000CA2369619A1 Caspase inhibitors and the use thereof
10/19/2000CA2369399A1 8-8, 6-6 and 6-8 catechin and epicatechin dimers and methods for their preparation
10/19/2000CA2369303A1 Method and composition for the treatment of cancer
10/18/2000EP1044260A1 Method for obtaining grape tannin, resulting tannin and uses
10/18/2000EP0773965B1 Gas phase production of polydienes
10/18/2000CN1270169A Benzopyrane derivatives and preparation thereof
10/17/2000US6133471 Process for producing chromans
10/17/2000US6133459 Method and compositions providing enhanced chemiluminescence from 1,2-dioxetanes
10/17/2000US6133446 Heterocyclic compounds for the treatment of CNS and cardiovascular disorders
10/17/2000US6133409 Reacting a solid support-bound n-alkylated hydroxamic acid with a carbon-nitrogen cleaving organometallic compund to liberate the product ketone
10/17/2000US6133309 Treatment of T-helper cell type 2-mediated immune disease by retinoid antagonists
10/17/2000US6133288 2,8-di(hydroxy)-5-((2-piperidin-1-yl)ethyoxy-1,4-phenylene)-)-5h -benzo-(e)naphtho(1,2-c)pyran; post-menopausal syndrome, osteoporosis, cardiovascular disorders; uterine fibrosis, endometriosis, and aortal smooth muscle cell proliferation
10/17/2000US6133286 Antagonists; antiinflammatory agents for rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, psoriasis and other skin disorders, e.g., eczema, erythema, pruritus and acne; stroke, reperfusion injury, grafting
10/17/2000US6133276 A ligand inhibitor of a crf/crf-binding protein complex to effect increased levels of crf; 2,4-dioxo- or 2-thiocarbonyl-4-oxo-5-(hydrocarbyl(thio)carbonylaminomethyl)-6-hydroxy-hexa-hexahydropyrimidines; alzheimer's, obesity; low side effects
10/12/2000WO1993012754A3 Tertiary and secondary amines as alpha-2 antagonists and serotonin uptake inhibitors
10/11/2000EP1043326A1 Steroid receptor modulator compounds and methods
10/11/2000EP1043325A1 Steroid receptor modulator compounds and methods
10/11/2000EP1043322A1 Vitamin e derivatives
10/11/2000EP1043315A1 Steroid receptor modulator compounds and methods
10/11/2000EP1042313A1 Benzopyran and benzothiopyran derivatives having retinoid antagonist like activity
10/11/2000EP1042312A1 PHOTOCHROMIC INDENO-FUSED NAPHTHO 2,1-b]PYRANS
10/11/2000EP1042311A1 PHOTOCHROMIC 6-ARYL SUBSTITUTED 3H-NAPHTHO 2,1-b]PYRANS
10/11/2000EP1042289A1 Indole]naphthopyrans, preparation, compositions and (co)polymer matrices containing them, synthesis intermediates
10/11/2000EP1041980A1 Acyl guanidine sodium/proton exchange inhibitors and method
10/11/2000EP1041979A1 Esters of conjugated linoleic acid or conjugated linolenic acid and uses thereof
10/11/2000EP0702689B1 Haptens, tracers, immunogens and antibodies for 3-phenyl-1-adamantaneacetic acids
10/11/2000CN1057292C Dicyclic compound, medicinal composition containing same and use thereof
10/10/2000US6130343 Overcoating tocopherol succinate powder with a solution containing binder; evaporating solvent
10/10/2000US6130342 CYP2D fluorescent assay reagents
10/10/2000US6130341 Reacting a phenol, formaldehyde and an alcohol; cyclization with an unsaturated compound
10/10/2000US6130227 7-Substituted camptothecin derivatives and methods for inhibiting the growth of tumor cells therewith
10/10/2000US6130101 Fluorescent probes for use in biological samples
10/05/2000WO2000058406A1 4,7-dichlororhodamine dyes useful as molecular probes
10/05/2000WO2000058300A1 Chroman derivatives
10/04/2000EP1041071A1 Methods for the preparation of coumarine derivatives
10/04/2000EP1041066A1 Steroid receptor modulator compounds and methods
10/04/2000EP1040826A1 Medicinal use of cromoglycic acid compounds
10/04/2000EP1040109A1 N-phenylamide and n-pyridylamide derivatives, method of preparing them and pharmaceutical compositions containing them
10/04/2000EP1040106A1 Carboxyl substituted chroman derivatives useful as beta 3 adrenoreceptor agonists
10/04/2000EP1040103A1 Anilide derivative, production and use thereof
10/04/2000CN1268512A Preparation method of scutellaria root extract
10/04/2000CN1057093C Lobed kudzuvine, and extraction and application thereof
09/2000
09/28/2000WO2000043095A3 Methods for separating a tocopherol from a tocopherol-containing mixture and compositions thereof
09/27/2000EP1038870A1 3,3-bis(aryl)-5-((N-(un)substituted)amido)naphthopyrans, their preparation, compositions and (co)polymer matrices containing them
09/27/2000EP1038863A2 Substituted dimeric compounds, process for their preparation and pharmaceutical compositions thereof
09/27/2000EP1038531A2 A composition comprising soybean isoflavones and a method for the production thereof
09/27/2000EP1037885A1 Novel water soluble photochromic compounds
09/27/2000EP1037628A1 Methods for preventing restenosis using tocotrienols
09/27/2000EP1037626A1 Multicatalytic protease inhibitors for use as anti-tumor agents
09/27/2000CN1268131A Process for preparing 3-isochromanome
09/27/2000CN1268130A Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
09/27/2000CN1056850C Synthetizing and refining process for trihydroxyethyl rutin
09/27/2000CN1056849C Fungistatin derivate and its preparing method and its application in pharmacy
09/26/2000US6124455 Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4-tetrahydroquinoline carboxylic acids, having an electron withdrawing substituent in the aromatic or heteroaromatic moiety, having retinoid-like biological activity
09/26/2000US6124347 Have inhibitory action against the formation of advanced glycation end-products and are useful as pharmaceuticals for the prevention and treatment of various adult diseases, especially diabetic complications
09/26/2000US6123959 Phospholipids, and competitive inhibitor(s) including arbutin of an enzyme for the synthesis of melanin, tyrosinase and non-competitive inhibitor(s) of tyrosinase selected from specified substituted 4-oxo-chromene compounds
09/21/2000WO2000055151A1 Photoactive pentaerythritol derivatives and orientation layers
09/20/2000EP1036792A1 Novel fragrance compound
09/20/2000EP1035845A1 Modulators of cysteine protease
09/20/2000CN1266851A Alpha-vitamine E cyclopropane carboxylate, vitamine E derivs. and preparing method thereof
09/19/2000US6121450 Non-steroidal compounds which are high affinity, high selectivity modulators for steroid receptors
09/19/2000US6121243 Prophylaxis of skin against ageing, against inflammation and for protection from photoreaction and oxidative influences
09/19/2000US6120696 Proton conductors in liquid form
09/19/2000CA2047550C Pharmaceutically useful anthracene compounds
09/14/2000WO2000053608A1 Pyridopyranoazepine derivatives, preparation and therapeutic use
09/14/2000WO2000053169A2 Method of inhibiting a chaperone protein
09/14/2000CA2367108A1 Method of inhibiting a chaperone protein
09/13/2000EP1035120A1 Alpha-tocopherol cyclopropylates, the new vitamin E derivatives, and method for producing the same
09/13/2000EP1034221A1 Dibenzorhodamine dyes useful as fluorescent labelling agents
09/13/2000EP0975617A4 Inhibitors of cholesterol esterase
09/12/2000US6117874 Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene B4 (LTB4 ) antagonists
09/12/2000US6117869 Compounds for and methods of inhibiting matrix metalloproteinases
09/08/2000WO2000051993A2 Dihetero-substituted metalloprotease inhibitors
09/08/2000WO2000051967A1 Oxyalkylene-substituted aminophenol intermediate
1 ... 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 ... 242